| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Akoya Biosciences (NASDAQ:AKYA) reported its Q3 earnings results on Wednesday, November 8, 2023 at 04:05 PM.
Here's what investors need to know about the announcement.
Akoya Biosciences beat estimated earnings by 29.73%, reporting an EPS of $-0.26 versus an estimate of $-0.37.
Revenue was up $6.36 million from the same period last year.
Last quarter the company missed on EPS by $0.07 which was followed by a 3.01% increase in the share price the next day.
Here's a look at Akoya Biosciences's past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.44 | -0.48 | -0.43 | -0.43 |
| EPS Actual | -0.51 | -0.49 | -0.50 | -0.47 |
| Revenue Estimate | 22.17M | 20.32M | 20.58M | 17.71M |
| Revenue Actual | 23.52M | 21.41M | 21.22M | 18.85M |
To track all earnings releases for Akoya Biosciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: AKYA
